Surrozen, Inc.
Status: Publicly traded
Direct answer
Surrozen, Inc. is publicly traded on NASDAQ under the ticker SRZN.
Surrozen, Inc. is a biotechnology firm dedicated to discovering and advancing pharmaceutical agents that precisely modify the Wnt pathway to facilitate tissue healing and regeneration. The company engineers specialized antibodies intended for use across a broad spectrum of medical conditions impacting organs such as the intestine, liver, eyes (retina, cornea), lungs, kidneys, inner ear (cochlea), skin, pancreas, and...
Can you invest in Surrozen, Inc.?
Yes. Surrozen, Inc. is publicly traded on NASDAQ under the ticker SRZN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Surrozen, Inc.
Detailed equity research is provided by MarketSnap.